NOONAN, DOUGLAS

NOONAN, DOUGLAS  

DIPARTIMENTO DI BIOTECNOLOGIE E SCIENZE DELLA VITA (DBSV)  

Mostra records
Risultati 1 - 20 di 289 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
A single cis-acting element in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding protein confers tissue- specific expression 1-gen-1995 Bobola, N; Hirsch, E; Albini, A; Altruda, F; Noonan, Douglas; Ravazzolo, R.
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo 1-gen-2004 Zacchigna, S; Zentilin, L; Morini, M; Dell'Eva, R; Noonan, Douglas; Albini, A; Giacca, M.
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies 1-gen-2019 Baci, D.; Bruno, A.; Cascini, C.; Gallazzi, M.; Mortara, L.; Sessa, F.; Pelosi, G.; Albini, A.; Noonan, D. M.
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways 1-gen-2018 Baci, D.; Bruno, A.; Bassani, B.; Tramacere, M.; Mortara, L.; Albini, A.; Noonan, D. M.
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein 1-gen-2001 Rusnati, M; Urbinati, C; Musulin, B; Ribatti, D; Albini, A; Noonan, Douglas; Marchisone, C; Waltenberger, J; Presta, M.
alpha-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis 1-gen-2004 Morini, M; Roccatagliata, L; Dell'Eva, R; Pedemonte, E; Furlan, R; Minghelli, S; Giunti, D; Pfeffer, U; Marchese, M; Noonan, Douglas; Mancardi, G; Albini, A; Uccelli, A.
Altered production of laminin and nidogen by high and low metastatic variants of murine melanoma cells 1-gen-1996 Valente, P; Noonan, Douglas; Ogle, Rc; Albini, A.
ALTERED STEADY-STATE MESSENGER-RNA LEVELS OF BASEMENT-MEMBRANE PROTEINS IN DIABETIC MOUSE KIDNEYS AND THROMBOXANE SYNTHASE INHIBITION 1-gen-1990 Ledbetter, S; Copeland, Ej; Noonan, Douglas; Vogeli, G; Hassell, Jr
Angiogenesis and cancer prevention: a vision 1-gen-2007 Noonan, Douglas; Benelli, R; Albini, A.
Angiogenesis at the interface between basic and clinical research 1-gen-1999 Albini, A; Noonan, Douglas; Santi, L.
ANGIOGENIC POTENTIAL IN-VIVO BY KAPOSIS-SARCOMA CELL-FREE SUPERNATANTS AND HIV-1 TAT PRODUCT - INHIBITION OF KS-LIKE LESIONS BY TISSUE INHIBITOR OF METALLOPROTEINASE-2 1-gen-1994 Albini, A; Fontanini, G; Masiello, L; Tacchetti, C; Bigini, D; Luzzi, P; Noonan, Douglas; Stetlerstevenson, Wg
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 1-gen-2018 Bruno, A.; Bassani, B.; D’Urso, D. G.; Pitaku, Ilvana; Cassinotti, E.; Pelosi, Giuliano; Boni, L.; Dominioni, L.; Noonan, D. M.; Mortara, L.; Albini, A.
Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy 1-gen-2012 Albini, A.; Noonan, D.
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies. 1-gen-2010 Sogno, I; Vene, R.; Ferrari, N.; De Censi, A.; Imperatori, ANDREA SELENITO; Noonan, Douglas; Tosetti, F.; Albini, A.
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target. 1-gen-2009 A., Albini; C., Brigati; A., Ventura; G., Lorusso; M., Pinter; M., Morini; A., Mancino; A., Sica; Noonan, Douglas
Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis 1-gen-2003 Benelli, R; Morini, M; Brigati, C; Noonan, Douglas; Albini, A.
Anti-angiogenesis in Search of Mechanisms: Angiostatin as a Prototype 1-gen-2005 Paleari, L; Brigati, C; Anfosso, L; Del'Eva, R; Albini, A; Noonan, Douglas
Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids 1-gen-2009 I., Sogno; N., Vannini; G., Lorusso; R., Cammarota; Noonan, Douglas; L., Generoso; M. B., Sporn; A., Albini
Anti-KS activity still a mystery 1-gen-1998 Noonan, Douglas; Albini, A.
Antiangiogenic activity of chemopreventive drugs 1-gen-2003 Pfeffer, U; Ferrari, N; Morini, M; Benelli, R; Noonan, Douglas; Albini, A.